Free Trial

Alimentation Couche-Tard (ATDBCN: Baa1/BBB+) ATD responds to 7-11's rejection

CONSUMER STAPLES

We start the week where we left off - M&A. Couche has responded to 7-11's rejection with some more direct language;

"Given the mutual benefits of a combination, we are disappointed in 7&i's refusal to engage in friendly discussions. We requested to have our advisors engage in discussions with the advisors to 7&i which was rejected...Couche-Tard has generated total shareholder return of over 450% in the last 10 years, more than 9 times greater than 7&i over the same period."

On financing it has added "highly confident that we have sufficient capacity to finance the transaction in cash". Last reports were it was seeking a mix of equity injection from pension funds and debt. Reminder full debt funding would move it from current net 2.1x to 5.2x leverage - we'd price 1-notch downgrades and significant supply across $/€/CAD - we do not doubt the co's focus on deleveraging from that.

It has finished with adding "highly focused on consummating a transaction". Echoing that 7-11 equities have moved to USD$15.3 overnight - a premium to ATD's original $14.86/share offer. Reminder regardless of funding mix and/or if this deal closes we would brace for supply - co has indicated M&A firepower at $10b - a $8.4b cash short-fall.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.